HEADER HYDROLASE 18-AUG-22 8E4R TITLE ROOM-TEMPERATURE X-RAY STRUCTURE OF SARS-COV-2 MAIN PROTEASE H41A TITLE 2 MINIPRECURSOR MUTANT IN COMPLEX WITH GC373 COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICASE POLYPROTEIN 1AB; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PP1AB,ORF1AB POLYPROTEIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HOMODIMER, CYSTEINE PROTEASE, PRECURSOR ENZYME, H41A MUTATION, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR L.COATES,D.W.KNELLER,A.KOVALEVSKY REVDAT 3 25-OCT-23 8E4R 1 REMARK REVDAT 2 30-NOV-22 8E4R 1 JRNL REVDAT 1 23-NOV-22 8E4R 0 JRNL AUTH A.KOVALEVSKY,L.COATES,D.W.KNELLER,R.GHIRLANDO,A.ANIANA, JRNL AUTH 2 N.T.NASHED,J.M.LOUIS JRNL TITL UNMASKING THE CONFORMATIONAL STABILITY AND INHIBITOR BINDING JRNL TITL 2 TO SARS-COV-2 MAIN PROTEASE ACTIVE SITE MUTANTS AND JRNL TITL 3 MINIPRECURSOR. JRNL REF J.MOL.BIOL. V. 434 67876 2022 JRNL REFN ESSN 1089-8638 JRNL PMID 36334779 JRNL DOI 10.1016/J.JMB.2022.167876 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.20.1_4487: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 57371 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 2780 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.2400 - 4.8800 0.98 2767 139 0.1362 0.1389 REMARK 3 2 4.8800 - 3.8800 1.00 2789 133 0.1176 0.1667 REMARK 3 3 3.8800 - 3.3900 1.00 2772 134 0.1425 0.1540 REMARK 3 4 3.3900 - 3.0800 1.00 2770 127 0.1669 0.1790 REMARK 3 5 3.0800 - 2.8600 1.00 2746 136 0.1709 0.2258 REMARK 3 6 2.8600 - 2.6900 1.00 2755 147 0.1809 0.1933 REMARK 3 7 2.6900 - 2.5500 1.00 2750 156 0.1779 0.1997 REMARK 3 8 2.5500 - 2.4400 1.00 2761 128 0.1780 0.2287 REMARK 3 9 2.4400 - 2.3500 1.00 2747 132 0.1795 0.2274 REMARK 3 10 2.3500 - 2.2700 1.00 2765 133 0.1714 0.1923 REMARK 3 11 2.2700 - 2.2000 1.00 2734 151 0.1715 0.2100 REMARK 3 12 2.2000 - 2.1300 0.99 2671 151 0.1767 0.2245 REMARK 3 13 2.1300 - 2.0800 0.99 2712 148 0.1772 0.1937 REMARK 3 14 2.0800 - 2.0300 0.99 2728 150 0.1942 0.2287 REMARK 3 15 2.0300 - 1.9800 0.99 2663 155 0.1950 0.2447 REMARK 3 16 1.9800 - 1.9400 0.99 2681 147 0.1952 0.2373 REMARK 3 17 1.9400 - 1.9000 0.98 2736 147 0.2046 0.2517 REMARK 3 18 1.9000 - 1.8600 0.98 2681 130 0.2178 0.2434 REMARK 3 19 1.8600 - 1.8300 0.98 2682 125 0.2420 0.3007 REMARK 3 20 1.8300 - 1.8000 0.97 2681 111 0.2546 0.3054 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.060 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4884 REMARK 3 ANGLE : 0.929 6648 REMARK 3 CHIRALITY : 0.057 751 REMARK 3 PLANARITY : 0.007 862 REMARK 3 DIHEDRAL : 7.820 674 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8E4R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1000267836. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER R 4M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSALISPRO REMARK 200 DATA SCALING SOFTWARE : CRYSALISPRO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57453 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 100.130 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.44600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.830 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6WQF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.65 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18-21% PEG3350, 0.1 M BIS-TRIS PH 6.5 REMARK 280 OR PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 287K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.06300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -7 REMARK 465 GLY A -6 REMARK 465 THR A -5 REMARK 465 SER A -4 REMARK 465 ALA A -3 REMARK 465 VAL A -2 REMARK 465 LEU A -1 REMARK 465 GLU A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 SER B -7 REMARK 465 GLY B -6 REMARK 465 THR B -5 REMARK 465 SER B -4 REMARK 465 ALA B -3 REMARK 465 VAL B -2 REMARK 465 LEU B -1 REMARK 465 GLU B 0 REMARK 465 SER B 1 REMARK 465 GLY B 2 REMARK 465 GLN B 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -122.87 49.15 REMARK 500 ASN A 51 77.62 -154.61 REMARK 500 ASN A 84 -123.92 56.16 REMARK 500 TYR A 154 -100.29 46.73 REMARK 500 PRO A 184 35.98 -88.82 REMARK 500 ASP B 33 -129.25 50.42 REMARK 500 ASN B 84 -121.12 52.43 REMARK 500 TYR B 154 -98.33 56.11 REMARK 500 PRO B 184 52.29 -92.34 REMARK 500 SER B 301 -31.75 -131.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (1S,2S)-2-({N-[(BENZYLOXY)CARBONYL]-L-LEUCYL}AMINO)- REMARK 630 1-HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1-SULFONIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 K36 A 401 REMARK 630 K36 B 401 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: PHQ LEU 04F REMARK 630 DETAILS: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8E4J RELATED DB: PDB REMARK 900 8E4J CONTAINS THE SAME PROTEIN IN THE LIGAND-FREE FORM DBREF 8E4R A -5 306 UNP P0DTD1 R1AB_SARS2 3258 3569 DBREF 8E4R B -5 306 UNP P0DTD1 R1AB_SARS2 3258 3569 SEQADV 8E4R SER A -7 UNP P0DTD1 EXPRESSION TAG SEQADV 8E4R GLY A -6 UNP P0DTD1 EXPRESSION TAG SEQADV 8E4R GLU A 0 UNP P0DTD1 GLN 3263 ENGINEERED MUTATION SEQADV 8E4R ALA A 41 UNP P0DTD1 HIS 3304 ENGINEERED MUTATION SEQADV 8E4R SER B -7 UNP P0DTD1 EXPRESSION TAG SEQADV 8E4R GLY B -6 UNP P0DTD1 EXPRESSION TAG SEQADV 8E4R GLU B 0 UNP P0DTD1 GLN 3263 ENGINEERED MUTATION SEQADV 8E4R ALA B 41 UNP P0DTD1 HIS 3304 ENGINEERED MUTATION SEQRES 1 A 314 SER GLY THR SER ALA VAL LEU GLU SER GLY PHE ARG LYS SEQRES 2 A 314 MET ALA PHE PRO SER GLY LYS VAL GLU GLY CYS MET VAL SEQRES 3 A 314 GLN VAL THR CYS GLY THR THR THR LEU ASN GLY LEU TRP SEQRES 4 A 314 LEU ASP ASP VAL VAL TYR CYS PRO ARG ALA VAL ILE CYS SEQRES 5 A 314 THR SER GLU ASP MET LEU ASN PRO ASN TYR GLU ASP LEU SEQRES 6 A 314 LEU ILE ARG LYS SER ASN HIS ASN PHE LEU VAL GLN ALA SEQRES 7 A 314 GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SER MET GLN SEQRES 8 A 314 ASN CYS VAL LEU LYS LEU LYS VAL ASP THR ALA ASN PRO SEQRES 9 A 314 LYS THR PRO LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY SEQRES 10 A 314 GLN THR PHE SER VAL LEU ALA CYS TYR ASN GLY SER PRO SEQRES 11 A 314 SER GLY VAL TYR GLN CYS ALA MET ARG PRO ASN PHE THR SEQRES 12 A 314 ILE LYS GLY SER PHE LEU ASN GLY SER CYS GLY SER VAL SEQRES 13 A 314 GLY PHE ASN ILE ASP TYR ASP CYS VAL SER PHE CYS TYR SEQRES 14 A 314 MET HIS HIS MET GLU LEU PRO THR GLY VAL HIS ALA GLY SEQRES 15 A 314 THR ASP LEU GLU GLY ASN PHE TYR GLY PRO PHE VAL ASP SEQRES 16 A 314 ARG GLN THR ALA GLN ALA ALA GLY THR ASP THR THR ILE SEQRES 17 A 314 THR VAL ASN VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE SEQRES 18 A 314 ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE THR THR THR SEQRES 19 A 314 LEU ASN ASP PHE ASN LEU VAL ALA MET LYS TYR ASN TYR SEQRES 20 A 314 GLU PRO LEU THR GLN ASP HIS VAL ASP ILE LEU GLY PRO SEQRES 21 A 314 LEU SER ALA GLN THR GLY ILE ALA VAL LEU ASP MET CYS SEQRES 22 A 314 ALA SER LEU LYS GLU LEU LEU GLN ASN GLY MET ASN GLY SEQRES 23 A 314 ARG THR ILE LEU GLY SER ALA LEU LEU GLU ASP GLU PHE SEQRES 24 A 314 THR PRO PHE ASP VAL VAL ARG GLN CYS SER GLY VAL THR SEQRES 25 A 314 PHE GLN SEQRES 1 B 314 SER GLY THR SER ALA VAL LEU GLU SER GLY PHE ARG LYS SEQRES 2 B 314 MET ALA PHE PRO SER GLY LYS VAL GLU GLY CYS MET VAL SEQRES 3 B 314 GLN VAL THR CYS GLY THR THR THR LEU ASN GLY LEU TRP SEQRES 4 B 314 LEU ASP ASP VAL VAL TYR CYS PRO ARG ALA VAL ILE CYS SEQRES 5 B 314 THR SER GLU ASP MET LEU ASN PRO ASN TYR GLU ASP LEU SEQRES 6 B 314 LEU ILE ARG LYS SER ASN HIS ASN PHE LEU VAL GLN ALA SEQRES 7 B 314 GLY ASN VAL GLN LEU ARG VAL ILE GLY HIS SER MET GLN SEQRES 8 B 314 ASN CYS VAL LEU LYS LEU LYS VAL ASP THR ALA ASN PRO SEQRES 9 B 314 LYS THR PRO LYS TYR LYS PHE VAL ARG ILE GLN PRO GLY SEQRES 10 B 314 GLN THR PHE SER VAL LEU ALA CYS TYR ASN GLY SER PRO SEQRES 11 B 314 SER GLY VAL TYR GLN CYS ALA MET ARG PRO ASN PHE THR SEQRES 12 B 314 ILE LYS GLY SER PHE LEU ASN GLY SER CYS GLY SER VAL SEQRES 13 B 314 GLY PHE ASN ILE ASP TYR ASP CYS VAL SER PHE CYS TYR SEQRES 14 B 314 MET HIS HIS MET GLU LEU PRO THR GLY VAL HIS ALA GLY SEQRES 15 B 314 THR ASP LEU GLU GLY ASN PHE TYR GLY PRO PHE VAL ASP SEQRES 16 B 314 ARG GLN THR ALA GLN ALA ALA GLY THR ASP THR THR ILE SEQRES 17 B 314 THR VAL ASN VAL LEU ALA TRP LEU TYR ALA ALA VAL ILE SEQRES 18 B 314 ASN GLY ASP ARG TRP PHE LEU ASN ARG PHE THR THR THR SEQRES 19 B 314 LEU ASN ASP PHE ASN LEU VAL ALA MET LYS TYR ASN TYR SEQRES 20 B 314 GLU PRO LEU THR GLN ASP HIS VAL ASP ILE LEU GLY PRO SEQRES 21 B 314 LEU SER ALA GLN THR GLY ILE ALA VAL LEU ASP MET CYS SEQRES 22 B 314 ALA SER LEU LYS GLU LEU LEU GLN ASN GLY MET ASN GLY SEQRES 23 B 314 ARG THR ILE LEU GLY SER ALA LEU LEU GLU ASP GLU PHE SEQRES 24 B 314 THR PRO PHE ASP VAL VAL ARG GLN CYS SER GLY VAL THR SEQRES 25 B 314 PHE GLN HET K36 A 401 29 HET K36 B 401 29 HETNAM K36 (1S,2S)-2-({N-[(BENZYLOXY)CARBONYL]-L-LEUCYL}AMINO)-1- HETNAM 2 K36 HYDROXY-3-[(3S)-2-OXOPYRROLIDIN-3-YL]PROPANE-1- HETNAM 3 K36 SULFONIC ACID HETSYN K36 GC376 FORMUL 3 K36 2(C21 H31 N3 O8 S) FORMUL 5 HOH *205(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 ALA A 41 CYS A 44 5 4 HELIX 3 AA3 GLU A 47 ASN A 51 5 5 HELIX 4 AA4 ASN A 53 ARG A 60 1 8 HELIX 5 AA5 SER A 62 HIS A 64 5 3 HELIX 6 AA6 ILE A 200 ASN A 214 1 15 HELIX 7 AA7 THR A 226 TYR A 237 1 12 HELIX 8 AA8 THR A 243 LEU A 250 1 8 HELIX 9 AA9 LEU A 250 GLY A 258 1 9 HELIX 10 AB1 ALA A 260 GLY A 275 1 16 HELIX 11 AB2 THR A 292 SER A 301 1 10 HELIX 12 AB3 SER B 10 GLY B 15 1 6 HELIX 13 AB4 ALA B 41 CYS B 44 5 4 HELIX 14 AB5 THR B 45 MET B 49 5 5 HELIX 15 AB6 ASN B 53 ARG B 60 1 8 HELIX 16 AB7 SER B 62 PHE B 66 5 5 HELIX 17 AB8 ILE B 200 ASN B 214 1 15 HELIX 18 AB9 THR B 226 TYR B 237 1 12 HELIX 19 AC1 THR B 243 LEU B 250 1 8 HELIX 20 AC2 LEU B 250 GLY B 258 1 9 HELIX 21 AC3 ALA B 260 ASN B 274 1 15 HELIX 22 AC4 THR B 292 GLY B 302 1 11 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N GLN A 83 O VAL A 86 SHEET 1 AA2 5 TYR A 101 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASP A 153 O CYS A 156 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 TYR A 101 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O PHE A 159 N LYS A 102 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O THR A 175 N MET A 162 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 LEU B 67 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N THR B 21 O LEU B 67 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N GLN B 83 O VAL B 86 SHEET 1 AA5 5 LYS B 100 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 AA6 3 LYS B 100 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O VAL B 157 N LYS B 100 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK SG CYS A 145 C21 K36 A 401 1555 1555 1.86 LINK SG CYS B 145 C21 K36 B 401 1555 1555 1.86 CRYST1 55.843 100.126 59.957 90.00 108.34 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017907 0.000000 0.005936 0.00000 SCALE2 0.000000 0.009987 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017571 0.00000